§ Mr. GregoryTo ask the Secretary of State for Health, pursuant to the reference made by the Minister of State to a new drug for those with Alzheimer's disease, in the debate on 17 April,Official Report, columns 515–16, what is the current position with regard to the testing and possible licensing of this drug.
§ Mrs. Virginia BottomleySection 118 of the Medicines Act 1968 precludes the disclosure of information relating to clinical trials or the processing of product licence applications.